89 related articles for article (PubMed ID: 26945965)
1. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
Zhang PP; Wang PQ; Qiao CP; Zhang Q; Zhang JP; Chen F; Zhang X; Xie WF; Yuan ZL; Li ZS; Chen YX
Cancer Lett; 2016 Jun; 376(1):95-103. PubMed ID: 26945965
[TBL] [Abstract][Full Text] [Related]
2. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.
Liu Y; Qi Y; Bai ZH; Ni CX; Ren QH; Xu WH; Xu J; Hu HG; Qiu L; Li JZ; He ZG; Zhang JP
Acta Pharmacol Sin; 2017 Jan; 38(1):120-132. PubMed ID: 27773936
[TBL] [Abstract][Full Text] [Related]
3. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
Liu F; Wu X; Jiang X; Qian Y; Gao J
J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis.
Li N; Yang C; Xia J; Wang W; Xiong W
Phytomedicine; 2024 Jun; 128():155338. PubMed ID: 38520835
[TBL] [Abstract][Full Text] [Related]
5. Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target.
Ma XL; Sun YF; Wang BL; Shen MN; Zhou Y; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Guo W; Yang XR
BMC Cancer; 2019 Aug; 19(1):760. PubMed ID: 31370822
[TBL] [Abstract][Full Text] [Related]
6. Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner.
Wang QL; Wang L; Li QY; Li HY; Lin L; Wei D; Xu JY; Luo XJ
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4447-4459. PubMed ID: 38108838
[TBL] [Abstract][Full Text] [Related]
7. Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice.
Huang H; Xue J; Xie ML; Xie T
Strahlenther Onkol; 2024 May; 200(5):444-452. PubMed ID: 37963994
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells.
Cusimano A; Puleio R; D'Alessandro N; Loria GR; McCubrey JA; Montalto G; Cervello M
Oncotarget; 2015 Jan; 6(3):1707-22. PubMed ID: 25596737
[TBL] [Abstract][Full Text] [Related]
9. Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids.
Seyama Y; Sudo K; Yamada T; Tsuchiya K; Nakamura Y
Biochem Biophys Res Commun; 2024 May; 709():149816. PubMed ID: 38547607
[TBL] [Abstract][Full Text] [Related]
10. MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization.
Cheng J; Liu C; Liu L; Chen X; Shan J; Shen J; Zhu W; Qian C
Oncotarget; 2016 Apr; 7(15):20597-611. PubMed ID: 26967560
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma.
Afonso MB; Rodrigues PM; Simão AL; Castro RE
J Clin Med; 2016 Mar; 5(3):. PubMed ID: 26950158
[TBL] [Abstract][Full Text] [Related]
12. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.
Li Q; Liu Z; Xu M; Xue Y; Yao B; Dou C; Jia Y; Wang Y; Tu K; Zheng X; Yao Y
Cancer Lett; 2016 May; 375(1):190-198. PubMed ID: 26945969
[TBL] [Abstract][Full Text] [Related]
13. Targeting miR-21 with Sophocarpine Inhibits Tumor Progression and Reverses Epithelial-Mesenchymal Transition in Head and Neck Cancer.
Liu W; Zhang B; Chen G; Wu W; Zhou L; Shi Y; Zeng Q; Li Y; Sun Y; Deng X; Wang F
Mol Ther; 2017 Sep; 25(9):2129-2139. PubMed ID: 28571917
[TBL] [Abstract][Full Text] [Related]
14. Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo.
Yang YS; Wen D; Zhao XF
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1263-1274. PubMed ID: 33409556
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of sophocarpine triflorohydrazone and its proliferation inhibition and apoptosis induction activity in myeloma cells through Notch3-p53 signaling activation.
Wang Y; Li W; Huang F; Wu X; Chen W; Dong M; Zhou J
Environ Toxicol; 2021 Apr; 36(4):484-490. PubMed ID: 33156571
[TBL] [Abstract][Full Text] [Related]
16. Sophocarpine Inhibits Tumorgenesis of Colorectal Cancer via Downregulation of MEK/ERK/VEGF Pathway.
Wang Q; Wang T; Zhu L; He N; Duan C; Deng W; Zhang H; Zhang X
Biol Pharm Bull; 2019 Nov; 42(11):1830-1838. PubMed ID: 31434836
[TBL] [Abstract][Full Text] [Related]
17. Sophocarpine inhibits the growth of gastric cancer cells via autophagy and apoptosis.
Huang Y; Chen X; Guo G; Guo W; Ma Q; Yuan J
Front Biosci (Landmark Ed); 2019 Mar; 24(4):616-627. PubMed ID: 30844702
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of sophocarpine in osteoarthritis: An in vitro and in vivo study.
Wu D; Zhu X; Kang X; Huang H; Yu J; Pan J; Zhang X
Int Immunopharmacol; 2019 Feb; 67():145-151. PubMed ID: 30551031
[TBL] [Abstract][Full Text] [Related]
19. A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine.
Wei S; Xiao J; Ju F; Liu J; Hu Z
Front Pharmacol; 2024; 15():1353234. PubMed ID: 38746009
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
